Skip to main content
by SciGen® Technologies S.A. All rights reserved.
HOPA 2019 - 15th Annual Conference
3 - 6 April, 2019 | Fort Worth, TX
Posters by ID
Posters by Title
Second-Generation (2-G) Tyrosine Kinase Inhibitor (TKI) Selection for the Treatment of Chronic Myeloid Leukemia (CML) Based on Comorbidity Prevalence: Analysis of United States Real-World Claims Data
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
No votes yet
Copyright © 2015-2019,
SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.
Enter Poster ID (e.gGoNextPreviousCurrent